Navigation Links
Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia
Date:8/20/2008

MONTREAL, Aug. 20 /PRNewswire/ -- Enobia Pharma, an emerging biotech company focused on developing novel therapeutics for serious bone disorders, today announced that the first patient in its clinical program for hypophosphatasia has been dosed. Enobia is investigating Enzyme Replacement Therapy (ERT) with ENB-0040 for the treatment of this rare and often crippling genetic bone disorder for which there is no approved treatment.

Under two separate protocols, ENB-0040 will be evaluated in both adults and infants afflicted with hypophosphatasia in Canada and the USA. "This may well be a milestone in the treatment of hypophosphatasia," said Michael Whyte, MD, Professor of Medicine at Washington University School of Medicine, St. Louis, MO, and consultant to Enobia Pharma. "Studies in a mouse model for hypophosphatasia show ENB-0040 has the potential to greatly enhance the quality-of-life for patients."

Under the first protocol, safety, tolerability and pharmacokinetics of ENB-0040 will be evaluated for one month in an open-label, dose escalation Phase I study of ENB-0040 delivered intravenously and subcutaneously to six adults with hypophosphatasia at three North American sites.

Under the second protocol, safety, tolerability, pharmacokinetics, and efficacy of ENB-0040 will also be evaluated in a six-month open label study of up to six infants with particularly severe hypophosphatasia. Key efficacy outcomes include assessment of skeletal and respiratory manifestations of the disease.

"In preclinical studies using a mouse model, ENB-0040 consistently improved survival as well as bone and dental manifestations of hypophosphatasia. The initiation of clinical studies brings us closer to the goal of providing drug therapy for hypophosphatasia patients where none currently exists," stated Robert Heft, PhD, Chief Executive Officer of Enobia.

About Hypophosphatasia

Hypophosphatasia is a rare, inherited, and sometimes fatal metabo
'/>"/>

SOURCE Enobia Pharma
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine technology :

1. Addrenex Pharmaceuticals New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
2. Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy
3. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
4. Pharmasset Reports Financial Results for Quarter Ended June 30, 2008
5. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
6. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
7. Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences
8. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
10. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
11. Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, United States Dental Devices Market ...reportlinker.com/p0158733/United-States-Dental-Dev..., United States Dental Devices Market Analysis ...eport is an essential source for in-depth informat...
(Date:11/25/2009)...Nov. 25 Swissray International, In...raphy ( ddR ) systems, announced today that its op...estor with a long term view towards growing Swissr...ed all assets and intellectual property, as well a...ss and growth Swissray is now poised to move to th...
(Date:11/25/2009)...v. 25 Cempra Pharmaceuticals Inc. ...ent and chief executive officer, will present at t...e at 8:50 a.m. EST, December 1, 2009, at The New Y...will provide an overview of the company,s two lead... of drug-resistant pathogens including MRSA. ,,...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Swissray International Announces New Ownership 2In Response to SEIU Lawsuit Judge Orders State to Halt Wage Cut For California Home Care Workers 50134 1Verathon Recognized Third Year in a Row as Outstanding Workplace in Washington State 50132 1Verathon Recognized Third Year in a Row as Outstanding Workplace in Washington State 50132 2AAHSA Statement on Long Term Services and Supports CBO Scoring 50130 1
... Feb. 23 People who start smoking before age 17...clerosis (MS), according to a study released today... Neurology,s 61st Annual Meeting in Seattle, April...ople with MS who were among more than 30,000 peopl...ed into three groups: non-smokers, early smokers (...
.... 23 /PRNewswire-FirstCall/ - Spectral Diagnostics...new findings demonstrating the clinical utility of...A cleared diagnostic for the measurement of endoto...mia congress. The conference took place in Tokyo, ...on the role of endotoxemia in sepsis. In addition ...
Other Medicine Technology:Young Smokers Increase Risk for Multiple Sclerosis 2Spectral presents data on the clinical utility of EAA(TM) at 13th Annual Critical Care for Endotoxemia conference in Japan 2
(Date:11/27/2009)... Specialist manufacturers who u...ts are saving millions of dollars by bringing in t...ess. Increasing numbers of pro-active medical manu... at the concept stage of their projects, ensuring ...design processes or potentially outdated technolog...
(Date:11/26/2009)... , PRINCETON, N.J., Nov. 27 T...lmost double over the next 25 years and annual med...336 billion, up from $113 billion today, according...abetes Care . The National Changing Diabetes ...missioned the analysis by a team from the Universi...
(Date:11/26/2009)...e that,s too big or too heavy can lead to strains ...y News) -- There may be nothing wrong with stuffin...want to do the same thing with your suitcase as yo...ople were treated in 2008 in U.S. hospital emergen...cal facilities for luggage-related injuries, such ...
(Date:11/26/2009)... Dr. David Kim of the Live Life...rgery in Dallas , is one of a growing number of ph...al networking sites to connect with individuals wh... to fight morbid obesity. Dr. Kim is utilizing Fac...tion about his practice with the community. , ...
(Date:11/26/2009)... Ennis & Ennis, P.A. is off...or users of Yaz and Yasmin birth control pills who...nary Embolism, Stroke, Heart Attack or other relat.... Women can call toll free at 1-800-856-6405 or go...aw.com and fill out an online case evaluation for...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3
... arrive at a hospital Emergency Department complai...icated CT scan. If the diagnosis is negative, the ...tal will be much shorter than it is today., That i...adiology at the University of Pennsylvania School ...
..., but replacing the hormone may not help, experts ...-- Men aged 40 or over with low levels of testoste...ks or death from any cause, a British study sugges...professor of clinical gerontology at the Universit...
... Line Screening, CLEVELAND, Nov. 27 A simple scr...hat discovered yesterday in Vice-President,Dick Ch...of the presence of,this irregular heart rhythm. In...ericans., Life Line Screening, the nation,s leadi...
...lliance Fund responded to the plan on HIV/AIDS iss..., Dr. Paul Zeitz, Executive Director of the Globa...t, and he and other experts will discuss the,issue...over while attending a high level meeting on AIDS ...
...ation system,developed in Japan will improve accur...identify victims of mass disasters, according to a...e Radiological Society of North,America (RSNA)., ...., dentist, radiologist and lecturer at the Depart...
...rt tissue dies. It is still not possible to restor... majority of stem cell researchers attempt to make...Winter of the Leiden University Medical Center, ho...sue died and that the remaining heart cells functi...
Other Medicine News:Health News:CT scans to determine heart disease in the emergency room 2Health News:Low Testosterone Might Shorten Men's Lives 2Health News:Low Testosterone Might Shorten Men's Lives 3Health News:Atrial Fibrillation Screening Can Identify Irregular Heartbeat That Leads to Stroke 2Health News:Senator Clinton's Plan 'The Kind of Leadership We Need on AIDS' 2Health News:New Automated System IDs Victims of Mass Disasters in Minutes 2Health News:New Automated System IDs Victims of Mass Disasters in Minutes 3
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: